Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
44.06
+0.77 (1.78%)
At close: Dec 20, 2024, 4:00 PM
43.80
-0.26 (-0.59%)
After-hours: Dec 20, 2024, 6:28 PM EST
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.41 billion as of December 20, 2024. Its market cap has increased by 83.98% in one year.
Market Cap
7.41B
Enterprise Value
5.95B
1-Year Change
83.98%
Ranking
Category
Stock Price
$44.06
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.41B, an increase of 350.71%. That is a compound annual growth rate of 36.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 7.41B | 57.04% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glaukos | 8.11B |
| Teleflex | 8.08B |
| Chemed | 7.81B |
| The Ensign Group | 7.73B |
| Jazz Pharmaceuticals | 7.32B |
| Madrigal Pharmaceuticals | 6.45B |
| Lantheus Holdings | 6.36B |
| Bausch + Lomb | 6.32B |